Sponsors (9)
The bill improves VA surveillance and produces timely recommendations to address cholangiocarcinoma among Vietnam-era veterans while offering a brief one-month benefits extension, at modest taxpayer cost and with risks of inconclusive findings and privacy concerns if data or study design are limited.
Vietnam-era veterans will get improved, disaggregated surveillance of cholangiocarcinoma through a VA/CDC study and continued VA Central Cancer Registry tracking, enabling the VA to better identify disease burden, target outreach, and inform care and benefits decisions.
Congress will receive actionable findings and recommendations within one year after study completion to guide administrative or legislative responses affecting veterans and related programs.
Veterans retain access to the benefit/protection in 38 U.S.C. §5503(d)(7) for one additional month (through Dec 31, 2021), providing a short-term extension of coverage.
If the study design or available data are limited, findings could be inconclusive, delaying policy changes or benefits decisions that veterans need.
Conducting the study, ongoing reporting, and the one-month extension will incur administrative and program costs for VA/CDC and slightly extend federal liability, which are ultimately funded by taxpayers.
Collecting and publishing disaggregated demographic and geographic data could raise privacy and re-identification concerns for veterans if not properly de-identified and protected.
Based on analysis of 3 sections of legislative text.
Directs VA, with CDC input, to study cholangiocarcinoma rates in Vietnam-theater veterans vs. U.S. residents and report results; extends a statutory date by one month.
Requires the Department of Veterans Affairs, with input from the CDC, to launch an epidemiological study to measure how common cholangiocarcinoma (bile duct cancer) is among veterans who served in the Vietnam theater compared with the general U.S. population, and to report findings and recommendations to Congress. Also makes a minor statutory date change by extending a deadline in current law from November 30, 2031 to December 31, 2031.
Introduced January 21, 2025 by Nicholas LaLota · Last progress April 8, 2025